FranΓ§aisπ See the interactive version (live chart) β
| Investment | Value today | Gain |
|---|---|---|
| 1 years ago (2025) | $866 | -13% |
| 3 years ago (2023) | $595 | -41% |
| 5 years ago (2021) | $729 | -27% |
| 10 years ago (2016) | $3,289 | +229% |
| since 2005 | $19,243 | +1824% |
| Year | Year's return | $1,000 invested at year start β worth today |
|---|---|---|
| 2026 (YTD) | +1% | $1,015 (+1%) |
| 2025 | -15% | $866 (-13%) |
| 2024 | -37% | $543 (-46%) |
| 2023 | +10% | $595 (-41%) |
| 2022 | -16% | $502 (-50%) |
| 2021 | +45% | $729 (-27%) |
| 2020 | +69% | $1,232 (+23%) |
| 2019 | +83% | $2,249 (+125%) |
| 2018 | +109% | $4,694 (+369%) |
| 2017 | -4% | $4,513 (+351%) |
| 2016 | -27% | $3,289 (+229%) |
π See the analyst analysis of Dexcom β
$1000 invested in Dexcom 5 years ago would be worth $729 today, and $3,289 over 10 years (price return, excluding dividends).
Calendar-year returns β 2024: -37%. 2025: -15%. 2026: +1%. Full breakdown in the table above.
Over 10 years, Dexcom's average annual return (CAGR) is about 13% per year, and -6%/yr over 5 years.
Best year: 2018 (+109%). Worst year: 2024 (-37%).
It's proportional β just multiply. Over 5 years, $1,000 invested in Dexcom is worth $729, so $100 would be worth a tenth, $5,000 five times more, and $10,000 ten times more. Use the calculator at the top of the page for your exact amount and chosen year.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Past performance, no predictive value and not investment advice. Prices in $, excluding dividends. Data: Yahoo Finance.